Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor

• Status: Unknown status
• Trial end date: 2016-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see if treatment with intrahepatic chemotherapy is a good options in patients with liver metastases. If the patients have colorectal cancer and never had got chemotherapy the investigators will use oxaliplatin together with capecitabine. If the patient is K-RAS wild type the investigators will add cetuximab. In patients who had received oxaliplatin or in patients with other cancers the investigators will use mitomycin and gemcitabine together with capecitabine.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Copenhagen University Hospital at Herlev
• Treatments: Gemcitabine; Mitomycin; Mitomycins; Oxaliplatin

Criteria

Inclusion Criteria:

• liver metastasis

• solid tumor

Exclusion Criteria:

• poor performance